December 2020
« Back to 2020
–
In Print
Monday, December 21, 2020
Matthew Herder and colleagues investigate how "Medicine regulators rely on pivotal clinical trials to make decisions about approving a new drug, but little is known about how they judge whether pivotal trials justify the approval of new drugs."